G1 THERAPEUTICS INC (GTHX) Stock Analyst Earnings Estimates
NASDAQ:GTHX - Nasdaq - US3621LQ1099 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 31.48M -30.49% | 51.3M 62.96% | 82.511M 60.84% | 75.014M -9.09% | 96.383M 28.49% | 110.55M 14.70% | 135.7M 22.75% | 169.54M 24.94% | 217.21M 28.12% | 276.74M 27.41% | |
| EBITDA YoY % growth | -141.99M -48.06% | -135.65M 4.47% | -39.014M 71.24% | -25.607M 34.36% | -13.449M 47.48% | 493.41M 3,768.83% | 30.784M -93.76% | 48.124M 56.33% | 60.925M 26.60% | 66.484M 9.12% | |
| EBIT YoY % growth | -142.46M -47.66% | -136.18M 4.41% | -39.527M 70.97% | -25.141M 36.39% | -11.615M 53.80% | 190.15M 1,737.11% | 4.944M -97.40% | 28.275M 471.91% | 72.453M 156.24% | 116.92M 61.37% | |
| Operating Margin | -452.54% | -265.46% | -47.91% | -33.52% | -12.05% | 172.00% | 3.64% | 16.68% | 33.36% | 42.25% | |
| EPS YoY % growth | -3.53 -34.22% | -3.39 3.97% | -0.95 71.98% | -0.42 55.71% | 0.05 112.73% | 0.22 319.05% | 0.22 | 0.50 122.73% | 0.85 70.41% | 1.34 56.89% |
All data in USD
| Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 70.13% | -0.13 38.99% | -0.16 18.91% | -0.13 -25.46% | -0.09 13.66% | -0.05 57.40% | -0.11 32.70% | -0.10 19.51% | -0.08 9.60% | -0.07 -19.63% |
| Revenue Q2Q % growth | 18.404M 49.63% | 21.041M 41.47% | 19.136M 32.19% | 21.706M 31.19% | 24.305M 32.06% | 26.657M 26.69% | 18.006M -5.91% | 19.163M -11.72% | 20.341M -16.31% | 22.134M -16.97% |
| EBITDA Q2Q % growth | -3.871M 75.78% | -7.65M 9.10% | -2.04M 77.15% | -2.04M 38.07% | -2.04M 47.30% | -2.04M 73.33% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.39M 73.18% | -7.195M 19.41% | -7.987M 11.73% | -4.38M -23.90% | -1.793M 59.15% | 1.814M 125.21% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -0.10 -171.43% | -0.17 | 0.07 | 40.58% |
| Q1 2024 Q2Q % growth | -0.20 62.26% | -0.21 | 0.01 | 4.63% |
| Q4 2023 Q2Q % growth | -0.21 71.23% | -0.28 | 0.07 | 25.19% |
| Q3 2023 Q2Q % growth | -0.35 40.68% | -0.34 | -0.01 | -4.30% |
| Q2 2023 Q2Q % growth | 0.14 115.22% | -0.22 | 0.36 | 162.75% |
| Q1 2023 Q2Q % growth | -0.53 53.91% | -0.65 | 0.12 | 18.81% |
| Q4 2022 Q2Q % growth | -0.73 22.34% | -0.86 | 0.13 | 15.20% |
| Q3 2022 Q2Q % growth | -0.59 41.00% | -0.64 | 0.05 | 8.51% |
| Q2 2022 Q2Q % growth | -0.92 2.13% | -1.04 | 0.12 | 11.46% |
| Q1 2022 Q2Q % growth | -1.15 -76.92% | -0.99 | -0.16 | -15.67% |
| Q4 2021 Q2Q % growth | -0.94 -40.30% | -1.06 | 0.12 | 10.96% |
| Q3 2021 Q2Q % growth | -1.00 -222.58% | -1.03 | 0.03 | 2.46% |
| Q2 2021 Q2Q % growth | -0.94 -13.25% | -0.99 | 0.05 | 5.31% |
| Q1 2021 Q2Q % growth | -0.65 20.73% | -1.09 | 0.44 | 40.58% |
| Q4 2020 Q2Q % growth | -0.67 28.72% | -0.92 | 0.25 | 26.88% |
| Q3 2020 Q2Q % growth | -0.31 63.95% | -0.31 | 0.00 | 0.35% |
| Q2 2020 Q2Q % growth | -0.83 -1.22% | -0.85 | 0.02 | 1.87% |
| Q1 2020 Q2Q % growth | -0.82 -28.12% | -1.00 | 0.18 | 17.73% |
| Q4 2019 Q2Q % growth | -0.94 | -0.98 | 0.04 | 3.96% |
| Q3 2019 Q2Q % growth | -0.86 | -0.87 | 0.01 | 1.07% |
| Q2 2019 Q2Q % growth | -0.82 | -0.74 | -0.08 | -11.00% |
| Q1 2019 Q2Q % growth | -0.64 | -0.74 | 0.10 | 12.94% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 16.546M -60.97% | 16.691M | -145K | -0.87% |
| Q1 2024 Q2Q % growth | 14.476M 11.82% | 15.564M | -1.088M | -6.99% |
| Q4 2023 Q2Q % growth | 14.873M 45.10% | 13.336M | 1.537M | 11.53% |
| Q3 2023 Q2Q % growth | 12.3M -47.84% | 14.513M | -2.213M | -15.25% |
| Q2 2023 Q2Q % growth | 42.392M 301.06% | 29.478M | 12.914M | 43.81% |
| Q1 2023 Q2Q % growth | 12.946M 87.62% | 11.419M | 1.527M | 13.37% |
| Q4 2022 Q2Q % growth | 10.25M 76.72% | 9.848M | 402K | 4.08% |
| Q3 2022 Q2Q % growth | 23.58M 385.19% | 23.741M | -161K | -0.68% |
| Q2 2022 Q2Q % growth | 10.57M 60.15% | 9.318M | 1.252M | 13.44% |
| Q1 2022 Q2Q % growth | 6.9M -51.48% | 6.821M | 79K | 1.16% |
| Q4 2021 Q2Q % growth | 5.8M -64.95% | 5.79M | 10K | 0.17% |
| Q3 2021 Q2Q % growth | 4.86M -81.73% | 5.281M | -421K | -7.97% |
| Q2 2021 Q2Q % growth | 6.6M 208.41% | 2.647M | 3.953M | 149.34% |
| Q1 2021 Q2Q % growth | 14.22M | 785.278K | 13.435M | 1,710.82% |
| Q4 2020 Q2Q % growth | 16.55M | 4.417M | 12.133M | 274.69% |
| Q3 2020 Q2Q % growth | 26.6M | 29.143M | -2.543M | -8.73% |
| Q2 2020 Q2Q % growth | 2.14M | 2.295M | -155K | -6.75% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 24.07% | -2.21% | 24.34% |
| Revenue | 0% | 0.2% | 2.96% | 1.77% |